Existing evidence indicates that activated microglia in the tumor microenvironment can inhibit the activity, function, and quantity of tumor-infiltrating lymphocytes (TILs, like CD4+ or CD8+ T cells) with anti-tumor effects. This evidence concerns the gene CD8A and neoplasm.